Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fitusiran long-term extension in hemophilia A or B
NCT02554773Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2015
- Primary completion
- Mar 2023
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 5
01
Overview
A Phase 2 trial of fitusiran in hemophilia A, hemophilia B (HB), sponsored by Sanofi. Started Sep 2015; status: completed.
02
Drugs
fitusiran
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT02554773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554773.